Probiotix Health

Probiotix Health R&D per Employee

The R&D Spending per Employee of Probiotix Health (PBX.AQ) as of Nov 3, 2026 is 14,000.00 GBP. In the previous year, R&D Spending per Employee was 15,500.00 GBP — a change of -9.68% (lower).

R&D per Employee

14,000.00GBP

YoY

-9.68%

Last updated:

R&D Spending per Employee of Probiotix Health is 2024 14,000.00 GBP. R&D Spending per Employee of Probiotix Health was 2023 15,500.00 GBP. It decreases by -9.68% lower compared to the previous year.

The Probiotix Health R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
97,450.00 GBP
Jan 1, 2020
2,350.00 GBP
Jan 1, 2022
2,000.00 GBP
Jan 1, 2023
15,500.00 GBP
Jan 1, 2024
14,000.00 GBP
The Probiotix Health R&D per Employee history
YEARR&D per EmployeeYoY
14,000.00GBP-9.68%
15,500.00GBP+675.00%
2,000.00GBP-14.89%
2,350.00GBP-97.59%
97,450.00GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Probiotix Health Stock analysis

What does Probiotix Health do? ProBiotix Health PLC develops probiotics to tackle cardiovascular disease and lifestyle conditions, focusing on cholesterol reduction through its LP-LDL ingredient. The company commercializes LP-LDL as an ingredient and in CholBiome products, including CholBiome, CholBiome X3, CholBiome BP, and CholBiome VH, which improve blood lipid profiles and blood pressure. ProBiotix leverages its OptiScreen and OptiBiotic platform technologies to identify metabolic pathways for potential health benefits across various diseases. The firm targets healthcare providers, supplement manufacturers, and consumers seeking natural solutions for cardiovascular health. ProBiotix Health PLC's revenue streams include selling LP-LDL as an ingredient to manufacturers and direct sales of CholBiome products under white-label and own-label arrangements. The CholBiome range serves segments such as cardiovascular health management, lifestyle disease prevention, and natural health supplements. The company's pipeline, driven by OptiScreen and OptiBiotic, supports future product development in metabolic health and disease-specific applications. The firm's business model centers on developing and commercializing probiotic solutions for cardiovascular health, with LP-LDL as the core product. CholBiome products are positioned for consumers and healthcare partners, while the OptiScreen and OptiBiotic platforms enable expansion into new therapeutic areas. ProBiotix's revenue comes from ingredient sales and branded product lines targeting health-conscious individuals and industry partners in the probiotic and supplement markets. Probiotix Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Probiotix Health stock

R&D Spending per Employee of Probiotix Health is 14,000.00 GBP in 2024.

R&D Spending per Employee of Probiotix Health changed from 15,500.00 GBP to 14,000.00 GBP, representing a -9.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Probiotix Health since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Probiotix Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Probiotix Health

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Probiotix Health